RxSight, Inc. Increase (Decrease) in Accounts Receivable
RxSight, Inc. (RXST) reported Increase (Decrease) in Accounts Receivable of -$4.66 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-05
- RxSight, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$3.73M.
- RxSight, Inc. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was -$936.00K, a 200.86% decline year-over-year.
- RxSight, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was -$788.00K, a 116.83% decline year-over-year.
- RxSight, Inc. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was -$3.91M.
- RxSight, Inc. increase (decrease) in accounts receivable for fiscal 2025 was -$6.66M, a 167.89% decline from fiscal 2024.
- RxSight, Inc. increase (decrease) in accounts receivable for fiscal 2024 was $9.80M, a 5.13% increase from fiscal 2023.
- RxSight, Inc. increase (decrease) in accounts receivable for fiscal 2023 was $9.32M, a 53.02% increase from fiscal 2022.
- RxSight, Inc. increase (decrease) in accounts receivable for fiscal 2022 was $6.09M, a 205.31% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$4.66M 10-Q · filed 2026-08-05 | -$5.45M derived: sum of 3 quarters · filed 2026-08-05 | -$9.36M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$936.00K 10-Q · filed 2026-05-06 | -$1.72M derived: sum of 2 quarters · filed 2026-05-06 | -$5.63M derived: sum of 3 quarters · filed 2026-05-06 | -$8.52M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$788.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$4.70M derived: sum of 2 quarters · filed 2026-02-25 | -$7.58M derived: sum of 3 quarters · filed 2026-08-05 | -$6.66M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$3.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$6.79M derived: sum of 2 quarters · filed 2026-08-05 | -$5.87M 10-Q · filed 2025-11-05 | -$1.19M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | -$2.89M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$1.96M 10-Q · filed 2026-08-05 | $2.72M derived: sum of 3 quarters · filed 2026-08-05 | $2.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $928.00K 10-Q · filed 2026-05-06 | $5.61M derived: sum of 2 quarters · filed 2026-05-06 | $5.29M derived: sum of 3 quarters · filed 2026-05-06 | $9.46M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $4.68M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $4.36M derived: sum of 2 quarters · filed 2026-02-25 | $8.53M derived: sum of 3 quarters · filed 2026-02-25 | $9.80M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$320.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $3.85M derived: sum of 2 quarters · filed 2025-11-05 | $5.12M 10-Q · filed 2025-11-05 | $10.16M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | $4.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $5.44M 10-Q · filed 2025-08-07 | $10.48M derived: sum of 3 quarters · filed 2026-02-25 | $12.43M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | $1.27M 10-Q · filed 2025-05-07 | $6.31M derived: sum of 2 quarters · filed 2026-02-25 | $8.26M derived: sum of 3 quarters · filed 2026-02-25 | $8.88M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | $5.04M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $6.99M derived: sum of 2 quarters · filed 2026-02-25 | $7.61M derived: sum of 3 quarters · filed 2026-02-25 | $9.32M 10-K · filed 2026-02-25 |
| 2023-09-30 | $1.95M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $2.58M derived: sum of 2 quarters · filed 2024-11-07 | $4.29M 10-Q · filed 2024-11-07 | $6.22M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $626.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-05 | $2.34M 10-Q · filed 2024-08-05 | $4.27M derived: sum of 3 quarters · filed 2025-02-25 | $6.41M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $1.71M 10-Q · filed 2024-05-06 | $3.65M derived: sum of 2 quarters · filed 2025-02-25 | $5.78M derived: sum of 3 quarters · filed 2025-02-25 | $7.04M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $4.07M derived: sum of 2 quarters · filed 2025-02-25 | $5.33M derived: sum of 3 quarters · filed 2025-02-25 | $6.09M 10-K · filed 2025-02-25 |
| 2022-09-30 | $2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $3.40M derived: sum of 2 quarters · filed 2023-11-09 | $4.16M 10-Q · filed 2023-11-09 | $4.66M derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | $1.26M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $2.02M 10-Q · filed 2023-08-07 | $2.53M derived: sum of 3 quarters · filed 2023-08-07 | $2.95M derived: sum of 4 quarters · filed 2023-08-07 |
| 2022-03-31 | $764.00K 10-Q · filed 2023-05-09 | $1.27M derived: sum of 2 quarters · filed 2023-05-09 | $1.69M derived: sum of 3 quarters · filed 2023-05-09 | $3.36M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $504.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $925.00K derived: sum of 2 quarters · filed 2023-03-06 | $2.60M derived: sum of 3 quarters · filed 2023-03-06 | $2.00M 10-K · filed 2023-03-06 |
| 2021-09-30 | $421.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.09M derived: sum of 2 quarters · filed 2022-11-07 | $1.49M 10-Q · filed 2022-11-07 | $2.92M derived: sum of 4 quarters · filed 2022-11-07 |
| 2021-06-30 | $1.67M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $1.07M 10-Q · filed 2022-08-08 | $2.50M derived: sum of 3 quarters · filed 2022-08-08 | $2.97M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | -$600.00K 10-Q · filed 2022-05-05 | $826.00K derived: sum of 2 quarters · filed 2022-05-05 | $1.30M derived: sum of 3 quarters · filed 2022-05-05 | |
| 2020-12-31 | $1.43M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $1.90M derived: sum of 2 quarters · filed 2022-03-08 | $2.08M 10-K · filed 2022-03-08 | |
| 2020-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $650.00K 10-Q · filed 2021-11-10 | ||
| 2020-06-30 | $175.00K 10-Q · filed 2021-09-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| STAAR SURGICAL CO (STAA) | United States | $0.957B | 362.70 |
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |